Feature | May 15, 2015

ECG Sensors on Smartphones Detect Atrial Fibrillation in the General Adult Public

Large study using the latest body-worn sensors for health tracking found to increase awareness of heart rate and behavior presented at Heart Rhythm 2015

HRS, ECG, smartphones, atrial fibrillation, AF, Heart Rhythm 2015

May 15, 2015 — A new, large-scale study has found adding an electrocardiogram (ECG) to the latest generation of body-worn sensors accurately detects atrial fibrillation (AF) and significantly increases awareness of heart rate and behavior. Body-worn or wearable wireless sensors are increasingly being used to help collect health-related information that can be shared with a doctor through a smartphone application. The study results show that by using ECG sensors with a smartphone application, the general adult population can efficiently track their heart rate data. The new findings were presented at Heart Rhythm 2015, the Heart Rhythm Society’s 36th annual scientific sessions.

More than 36 million Americans currently use body-worn sensors for activity and heart rate tracking and the trend is on the rise. This population is expected to grow to 135 million by 2018. Additionally, AF, the most common heart arrhythmia, affects more than 2.7 million American adults and its presence is increasing rapidly. In the next 30-40 years, the number of people diagnosed with AF in the United States is expected to more than double. This increased access to heart rhythm data will be even more important as the prevalence of AF grows.

Study participants were provided with a smartphone-enabled ECG sensor from AliveCor and had their ECG and heart rate data evaluated over a six-month period. The device records a 30-second ECG and wirelessly transmits the recording to a secure cloud-based server. Participants were also asked to download a mobile software application that facilitated ECG acquisition and access to ECG interpretation.

More than 800 study participants transmitted 57,703 ECGs during the six-month period. Chronic health conditions were reported by 113 participants and only 21 participants were taking any medication. AF was detected in 185 recordings in 93 unique subjects (11 percent). After 30 days of use, the majority of participants (73 percent) stated they were more aware of their heart rate and behavior.

“Having an ECG device on smartphones is quite incredible because it makes tracking heart health and behavior accessible to almost anyone. The experience of using an ECG device through a smartphone creates opportunities for people to truly pay attention and understand their heart rhythm,” said lead author Leslie A. Saxon, M.D., executive director of the University of Southern California Center for Body Computing. “Not only does using these type of smartphone apps allow the patient to be more informed, but it also allows their physician the ability to access and analyze real-world data which can ultimately help improve treatment and overall quality of care.”

As use of body-worn sensors and health tracking smartphone applications increases, the ability to chronicle and store the population’s ECGs will lead to greater understanding of cardiac behavior and heart rhythm disorders like AF. Heart rhythm is dynamic and the portability and wireless connectivity of smartphone-enabled ECG devices will provide unprecedented public access to screening, diagnostic and monitoring data.

For more information: www.hrsonline.org

Related Content

News | Cardiovascular Clinical Studies

May 26, 2022 — For more than 20 years, scientists have known that people with hypertension, diabetes, high cholesterol ...

Home May 26, 2022
Home
News | Cardiovascular Clinical Studies

May 25, 2022 — Researchers from the group of Eva van Rooij used advanced sequencing technology to better understand the ...

Home May 25, 2022
Home
News | Cardiovascular Clinical Studies

May 23, 2022 — A specific protein in blood vessel cells plays a major role in the development of vascular and ...

Home May 23, 2022
Home
News | Cardiovascular Clinical Studies

May 20, 2022 — Results from a real-world study investigating safety and effectiveness of clopidogrel versus aspirin ...

Home May 20, 2022
Home
News | Cardiovascular Clinical Studies

May 11, 2022 — Hypertrophic cardiomyopathy is a heart disease that leads to a stressed, swollen heart muscle. Due to a ...

Home May 11, 2022
Home
News | Cardiovascular Clinical Studies

May 5, 2022 — High-level results from the DELIVER Phase III trial showed AstraZeneca’s FARXIGA (dapagliflozin) reached a ...

Home May 05, 2022
Home
News | Cardiovascular Clinical Studies

April 7, 2022 – Patients with tricuspid regurgitation, a common and debilitating form of valvular heart disease, who ...

Home April 07, 2022
Home
News | Cardiovascular Clinical Studies

April 7, 2022 – While there are effective therapies to reduce the risk of heart disease by lowering low-density ...

Home April 06, 2022
Home
News | Cardiovascular Clinical Studies

March 25, 2022 – Despite recent efforts to improve women’s leadership in cardiovascular clinical trial research over the ...

Home March 25, 2022
Home
News | Cardiovascular Clinical Studies

We are launching something new—a Clinical Case of the Month—and we want you to contribute! Do you have a clinical case ...

Home February 17, 2022
Home
Subscribe Now